Just a moment, the page is loading...
The Supported Studies Programme

For the latest updates on GSK’s response to COVID-19, please click here.

Africa Open Lab


Concept Proposal ReviewFull Proposal ReviewProposal of Interest
Submission period for concept opensSubmission period for concept closesConcept review outcome communicatedSubmission for full proposal opensSubmission for full proposal closesFull proposal Outcome communicatedNext step: Draft protocol submission for review
27th November 2023 (13:00 GMT)29th January 2024  (17:00 GMT)30th April 202430th April 20245th July 202420th September 2024 By 20th December 2024

The Africa Open Lab concept submission period is closed.

[Africa Open Lab Proposal submissions:]
The Africa Open Lab is inviting applications from African scientists at an early stage of their career with an interest in conducting research in infectious diseases.

We strive to enable awardees to develop their research careers through offering funding for a research project and invaluable mentoring while they conduct their innovative research projects.

Africa Open Lab call is for proposals of relevance to the understanding of infectious disease epidemiology, aetiology, prevention and control; proposals addressing significant gaps in knowledge as well as mechanisms to improve access to medicines and vaccines for infectious diseases in Africa.

Proposals must demonstrate the specific health needs their research will address and how they will engage with specific stakeholders to bring about change in health policy and practice.

The research project may consist of population-based or clinical studies, laboratory-based analysis of field or clinical samples; but projects focused solely on studies in vitro or using animal models will {not} be considered.

[The applications are invited in the following disease areas:]
o   Malaria
o   Tuberculosis
o   Antimicrobial resistance (AMR) linked to bacterial infections
o   Enteric infections
o   Other (Neglected Tropical Disease and emerging infectious diseases of particular relevance for Africa)

© 2001-2024 GlaxoSmithKline plc. All rights reserved. Registered in England and Wales No. 3888792.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.